Health

Zoom entered into two definitive agreements to acquire Five9, a leading contact center software based on cloud technology, for $14.7B and Kites, which provides real-time Machine Translation solutions. [more]

Patients hospitalized by COVID-19 that end up in intensive care are likely to be diagnosed with acute kidney injury (AKI), face few treatment options and a high mortality rate, but a new potential option is on the way. [more]

In a few short months, ScreenPro Security has emerged as a one-stop shop for Canadian COVID-19 testing and international travelers needing digital COVID-19 passport capabilities. [more]

Investors inject cash into Eupraxia Pharmaceuticals during its IPO on the TSX. The funds will be used to support clinical trials of their leading knee osteoarthritis treatment. Eupraxia’s polymer technology promises to flatten the drug-dose curve, providing long-term pain relief (up to 6 months) with fewer side effects. [more]

Propelled by surging eCommerce, Drizly cashes in on shuttered bars with sale to Uber. It is the second major deal in the last year for Uber after buying Postmates for $2.65 billion in 2020. [more]

WELL Health’s buying spree continues with a major acquisition with C$302.5M financing led by Mr. Li Ka-shing. The acquisition will add annual revenue of US$100M with a run-rate of US$120 million to Well Health’s books. CRH currently has an EBITDA operating margin of 40%. [more]

Plant-based food technology is revolutionizing the way we see food. Texture and flavour innovations combined with lower environmental and health costs support remarkable product growth to meet consumer demand. [more]

After its public listing last October, shares in Canbud appear poised to move higher as it executes on its three-pronged business model: 1) Hemp for cannabinoids (CBD) production, (2) Mushrooms for both psychedelic pharmaceuticals and non-psychedelic nutraceuticals, and (3) Plant-based products. [more]